Holy Stone Healthcare Co Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Holy Stone Healthcare Co., Ltd. plant passes GMP assessment
Holy Stone Healthcare Co., Ltd:Shinchu-based plant passed good manufacturing practice (GMP) assessment.New drug IBD98-M will be developed and produced at plant.
Latest Developments forHoly Stone Healthcare Co Ltd
Latest Key Developments inPharmaceuticals
- AbbVie Inc extends exchange offer to acquire Pharmacyclics, Inc.
- Celgene Corp announces analysis of REVLIMID (Lenalidomide) in patients with non-del-5Q MDS demonstrated improved health related quality of life measures
- Cambrex Corp reaffirms FY 2015 outlook
- Pernix Therapeutics Holdings Inc gives FY 2015 guidance
- Share this
- Digg this